Modulation of mammalian cell proliferation by a modified tRNA base of bacterial origin  by Langgut, Werner et al.
Volume 336, number 1, 137-142 FEBS 13393 
0 1993 Federation of European Bi~hemi~l Societies 00145793/93/$6.~ 
December 1993 
Modulation of mammalian cell proliferation by a modified tRNA base 
of bacterial origin 
Werner Langguta,*, Thomas Reissera, Susumu Nishimurab***, Helga Kerstena 
“Institut fir Biochemie der Medizinischen Fukult&t, Universitiit Erlangen-Niirnberg, Fahrstrasse I 7, D-91054 Erlungen, Germany 
bBiology Division, National Cancer Center Research Insitute, Tsukiji-J-chome, chuo-ku, Tokyo, Japan 
Received 29 October 1993 
Addition of the q-base to q-deficient non-transformed mammalian cells stimulated their proliferation. The q-base also improved proliferation of 
some cancer-derived cell lines, but inhibited proliferation of others. The proliferation of HeLa-S3 carcinoma cells was stimulated by q under aerobic 
conditions, but was inhibited when the cells had shifted their energy metabolism towards glycolysis as the result of oxygen limitation. Q-deficient 
cells could not adapt their proliferation to the respective oxygen tension. The q-base stimulated the proliferation of non-transformed fibroblasts 
but inhibited proliferation of the same cell line, when aerobic glycolysis was increased after transformation with the ras gene. The results suggest 
that the q-base permits mammalian cells to adapt their proliferation to their specific metabolic state. 
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1. I~RODUCTION 
More than 50 different modified nucleosides have 
been characterized in tRNA [l], yet their functional role 
is not clear. Many of these modifications are not essen- 
tial for tRNA function but may be involved in regula- 
tion. The highly modified tRNA nucleoside, queuosine 
(Q), replaces guanosine (G) in position 34 of the anti- 
codon of bacterial and eukaryotic tRNAs,, [2-4]. 
Queuosine is synthesized by eubacteria, involving 
unique ~-ade~osylmethionine- and vitamin B12-de- 
pendent steps [S-S]. The occurrence of Q~ontain~g 
tRNAs is highly conserved throughout the animal king- 
dom [2,3]. However, mammals cannot synthesize Q but 
are supplied with the free q-base (queuine, in analogy 
to guanine)-derived from bacterial tRNA- by nutrition 
and by their intestinal flora [9]. The eukaryotic 
tRNA:guanine transglycosylase (EC 2.4.2.29) replaces 
guanine (g) with queuine (q) in the corresponding 
tRNAs in a base for base exchange reaction without 
breakeage of the sugar phosphate backbone [9]. Thus, 
q is present in mammals as a free base outside and inside 
the cell, and in a tRNA-bound state within the cell. 
H~omodi~cation of Q-tRNAs is frequently ob- 
served in neoplastica~y tr~sfo~ed cells and has been 
linked with the proliferative capability and/or malig- 
nancy of such cells [l&13]. Intraperitonial injection of 
q into ascites tumor bearing mice relieves Q-deficiency 
of tRNAs, correlating with i~ibition of tumor growth 
[ 141. Characteristic fluctuations in the amount of hypo- 
modified Q-tRNAs are associated with the transition 
from a proliferative stage to differentiation [2]. The ‘Q- 
system’ - comprising the free q-base and its tRNA- 
bound state, queuosine - participates in control mecha- 
nisms gouveming oxidative and glycolytic metabolism 
[15-181. Q-modification of tRNAs was proposed to be 
related to changes in saturation density in primary skin 
fibroblasts. [19]. HeLa cells grown in medium supple- 
mented with q-free horse serum [3] do not contain Q in 
tRNA (q-deficient cells). Addition of chemically synthe- 
sized q to these cells modulates their proliferation de- 
pending on oxygen availability [20]. It was proposed 
that q interacts with regulatory proteins responsible for 
growth control, as deduced from changes in the expres- 
sion of the growth-associated genes c-fos and c-myc [21], 
and in the tyrosine phosphorylation of specific mem- 
brane-associated proteins [22]. In addition, the q-base 
modulates the autophosphorylation activity of the re- 
ceptor for epidermal growth factor (EGF) in vitro and 
in intact cells and inhibits EGF-supported proliferation 
of HeLa cells 1231. A possible involvement of queuinel 
Q-tRNAs in mechanisms of growth control has been 
proposed also by French et al. [24], who described that 
q prevents differentiation and favours proliferation of 
HL-60 cells. 
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Here we have investigated the effect of q on the pro- 
liferation of non-transformed cell lines, tumor-derived 
cell lines, and cells transformed by the activation of 
discrete oncogenes. The results suggest hat q is a mod- 
ulator of the proliferation of mammalian cells in cul- 
ture. Queuine can act as a growth-stimulator or as a 
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growth-inhibitor, depending on the aerobic or glyco- 
lytic state of cells. 
2. MATERIALS AND METHODS 
Minimum essential medium (MEM), Dulbecco’s modified Eagle’s 
medium (DMEM), RPM1 1640 medium, and dialyzed fetal calf serum 
(dFCS) were from Gibco/BRL (Germany, Japan). Queuine-free adult 
horse serum [3] was from Boehringer Mannheim (Germany). 
[S-‘Hlguaninesulfate was synthesized by Amersham (Germany). The 
q-base was synthesized by Drs. H. Akimoto and H. Nomura of the 
Central Research Laboratories, Takeda Chemical Ind. Ltd., Osaka, 
Japan [Z]. 
Mammalian cells were cultivated aerobically in an atmosphere of 
95% air and 5% CO*, and under hypoxic conditions in an incubator 
from Labotect, Germany, in which the atmosphere was replaced by 
nitrogen to an oxygen content of 7%. Non-transformed, established 
cell lines: human epithelial-like hepatocytes (Chang Liver) and embry- 
onic lung fibroblasts (Wi-38); mouse embryonic fibroblasts (NIH- 
3T3). Cancer-derived cell lines: human epithelial-like cervical carci- 
noma cells (HeLa-S3), lymphoblast-like promyelocytic leukemia cells 
(HL-60), epithelial-like vulva1 carcinoma cells (A-431), and colon 
adenocarcinoma cells (Colo-DM320); rat adrenal pheochromocytoma 
cells (PC-12); mouse Ehrlich Lettre Ascites tumor cells (EAT). The cell 
lines Chang Liver, PC-12, and Wi-38 were purchased from the Amer- 
ican Type Culture Collection (ATCC). The cell lines HeLa-S3, EAT, 
and HL-60 were provided by Dr. A. Ogilvie, and Colo-DM320 by Dr. 
T. Dingermann (Erlangen, Germany). A-431 cells were provided by 
Dr. K. Yamane (National Cancer Center Research Institute, Tokyo, 
Japan); non-transformed NIH-3T3 fibroblasts and NIH-3T3 cells 
transformed by the activated c-Ha-ras gene [26] were provided by Dr. 
T. Sakiya, c-Ki-ras-transformed NIH-3T3 cells by Dr. Y. Taya, N-ras- 
transformed NIH-3T3 cells by Dr. M. Terada, and raf-transformed 
NIH-3T3 cells [27] by Dr. M. Nagao (National Cancer Center Re- 
search Institute, Tokyo, Japan). NIH-3T3 cells transformed with the 
erbB-2 gene [28] were provided by Dr. T. Yamamoto (Institute of 
Medical Sciences, University of Tokyo, Japan). Cells were grown and 
maintained in MEM supplemented with 10% q-free horse serum or 
dialyzed fetal calf serum. RPM1 1640 medium was used in the case of 
HL-60 cells. A-431 cells were cultivated in DMEM/lO% dFCS, and 
NIH-3T3 cells and the respective ras-, e&3-2-, and raf-transformed 
cells in DMEMIS% dFCS. Cells were seeded to 10 cm culture dishes 
or 24-well culture vessels at low density and precultivated for 2 or 3 
days without queuine. The medium was then replaced with fresh 
medium, and the cells were further incubated either with or without 
q (final concentration 300 nM). Wi-38 cells and Colo-DM320 cells 
were supplied with q without exchange of the medium. HL-60 cells and 
EAT-cells were seeded directly into q-containing or q-free medium 
without precultivation. Adherent growing cells were detached by tryp- 
sinization and collected by centrifugation. The cell number was deter- 
mined either microscopically by counting in a Fuchs/Rosenthal cham- 
ber, or automatically with a coulter counter (CASY 1, Schlrfe System, 
Germany). For the statistical evaluation of the data from repeated 
experiments, the increase in the cell number of (+q)-cultures after 
addition of q was determined at the point of maximal response to q, 
and is expressed as fold increase in the cell number of (-q)-cultures 
(relative increase A+q/A-q) within the same period. 
For the determination of total specific LDH activity, cells were 
grown without q for 3 days under aerobic or hypoxic conditions. The 
culture medium was exchanged and the cells were harvested 24 h later. 
Total LDH activity in cytosolic extracts was measured spectro- 
photometrically according to Schwarz and Bodansky [29]. 
For the isolation of tRNA, cells (l-5 x 10’ for each analysis) were 
collected by scraping and centrifugation, washed with PBS, frozen in 
liquid nitrogen, and stored until use at -2O’C. The frozen cell pellet 
was overlayed with 2 ml acetate buffer (140 mM Na-acetate, pH 4.5) 
and 2 ml phenol. The sample was mixed vigorously for 1 h at room 
temperature. The aqueous phase was collected, extracted once with 
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chloroform/isoamylalcohol(24: 1),and loaded onto a DEAE-cellulose 
column (Whatman DE52, 1 ml volume) equilibrated with acetate 
buffer. The column was washed with 0.35 M NaCl in acetate buffer, 
and the tRNA was eluted with 0.55 M NaCl. Nucleic acid was precip- 
itated with 0.8 vol of isopropanol, collected by centrifugation at 10,000 
g, washed with 70% ethanol, dried under vacuum, and re-dessolved 
in 1 ml 10 mM Tris/HCl, pH 8.0. The extent of tRNA modification 
with Q was determined as described by Okada et al. [lo] using the E. 
coli tRNA:guanine transglycosylase. This enzyme catalyzes the ex- 
change of tRNA-bound guanine for radioactive guanine specifically 
at position 34 of the tRNAs of the Q-family, but cannot exchange 
tRNA-bound queuine for guanine. Therefore, the guanine acceptance 
of tRNA is a measure for the extent of Q-modification. 
3. RESULTS 
3.1. Queuine can act as promoter or as inhibitor of mam- 
malian cell proliferation 
The effect of q on the proliferation of established 
non-transformed cell lines and cancer-derived cells was 
investigated. Cells were grown and maintained in q-free 
medium and therefore did not contain Q in tRNA. The 
addition of q to q-deficient non-transformed human 
and mouse cells (Chang Liver, NIH-3T3, and Wi-38) 
stimulated their proliferation (Fig. 1A). The response of 
cancer-derived, q-deficient cells to the addition of q can 
be divided into two categories (Fig. 1B): (i) proliferation 
was stimulated in the case of the human cell lines HeLa- 
S3, A-431, and HL-60; (ii) proliferation was inhibited 
after addition of q in the case of Colo-DM320 cells, 
PC-12 cells, and Ascites tumor cells (EAT). The results 
show that q can act as a positive or a negative modula- 
tor of the proliferation of cultured mammalian cells. 
Growth-modulation by q in the case of cancer-derived 
cells apparently is cell-type specific, suggesting that a 
certain type of predisposition of the cell determines 
whether q stimulates or inhibits proliferation. 
3.2. Modulation of proliferation by q is related to the 
activation of discrete oncogenes 
Inhibition of proliferation by q was observable in 
cancer-derived cells but not in non-transformed cells. 
We therefore reasoned that growth inhibition might be 
related to the activation pattern of cellular oncogenes. 
Therefore, the effect of q-addition on proliferation was 
compared between q-deficient non-transformed NIH- 
3T3 cells and the same cell line that was transformed 
with the activated oncogenes c-Ha-ras, c-Ki-ras, N-ras, 
c-erbB-2 and c-raf, respectively. NIH-3T3 cells showed 
a maximal response already 24 h after addition of q 
(Fig. 1). We therefore chose this point (comprising ap- 
proximately one population doubling) to measure dif- 
ferences in the proliferation of the respective cell lines 
(Table I). Addition of q to q-deficient NIH-3T3 cells 
stimulated their proliferation within 24 h of further in- 
cubation under aerobic conditions. However, prolifera- 
tion of NIH-3T3 cells transformed with the activated 
oncogenes c-Ha-ras, N-ras, c-Ki-ras, and c-erbB-2 was 
inhibited after addition of q. In contrast, NIH-3T3 cells 
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Fig. 1. Proliferation of non-transformed (A) and cancerderived mammalian cells (B) in the absence (u) or presence (4) of q. The cells were 
precultivated in the absence of q. At t = 0, half of the cultures were supplied with 300 nM q, the second half received no q. The total cell number 
per culture vessel was determined at the indicated times after addition of q. Numbers within blot frames show in the following order: the mean 
value of the relative increase (d+q/d-q) in cell number of +q-cultures f variation found in repeatet experiments (see method section), the time after 
q-addition when these values were obtained, and the number of experiments performed with the respective cell line. 
transformed with the activated c-ruf gene, responded 
only very little to supplementation with q; at least, no 
inhibition of proliferation was observed after addition 
of q to these cells. The results indicate that positive or 
negative modulation of the proliferation of transformed 
cells by q might depend on the activation of discrete 
oncogenes. 
3.3. Modulation of proliferation by q is related to the 
metabolic state 
Q-deficient HeLa cells grew equally well under aero- 
bic and under hypoxic conditions. (Fig. 2). In the pres- 
ence of q, proliferation of HeLa cells was improved 
under aerobic but reduced under hypoxic conditions, 
indicating that the q-base is essential for this kind of 
growth-regulation. Based on these results we assumed 
that growth-modulation by q might depend on whether 
the cells have a more aerobic or a more glycolytic met- 
abolic predisposition. We therefore investigated meta- 
bolic changes caused by hypoxia. Under reduced oxy- 
gen tension, HeLa cells activate transcription of the Idh 
a gene, coding for lactate dehydrogenase A (LDH A), 
the terminal enzyme of anaerobic glycolysis in mam- 
mals [30]. This induced gene expression is paralleled by 
an increase in the amount of LDH A protein, and also 
an increased activity of the muscle type isoenzyme LDH 
5, the homotetrameric form of LDH A (LDH A4). Spe- 
cific LDH activity was about twice as high in hypoxi- 
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Fig. 2. Proliferation of q-deficient (-q) and q-supplemented (+q) 
HeLa cells under aerobic and hypoxic conditions. The relative increase 
in cell number is expressed as percentage of the cell number of aerobi- 
cally grown q-deficient cells. Values are means from five independent 
experiments. 
tally than in aerobically growing, q-deficient HeLa cells 
(Fig. 3) suggesting that hypoxically growing cells had 
shifted their energy metabolism towards glycolysis. On- 
cogen activation has been shown to increase glycolysis 
and LDH activity in rat cells under aerobic conditions 
[31,32]. Specific LDH activity was two-fold higher in 
rus-transformed NIH-3T3 cells than in non-trans- 
formed cells (Fig. 3), suggesting that aerobic glycolysis 
is increased also in mouse fibroblasts after activation of 
the ras gene. This was confirmed by the observation 
that rus-transformed cells also showed a three-fold 
higher rate of lactate production than the non-trans- 
formed cells (not shown). The results indicate that mod- 
ulation of cell proliferation by q is related to the switch 
from an oxygenated to a more glycolytic state of the cell. 
3.4. Modification of tRNAs with q 
The extent of modification of tRNAs with q was 
Table I 
Differential modulation of the proliferation of normal and trans- 
formed fibroblasts by q 
Cell line Relative increase in 
cell number (d+q/d-q) 
NIH-3T3 non-transformed 
Ki-rus-transformed NIH-3T3 
Ha-ras-transformed NIH-3T3 
N-ra-transformed NIH-3T3 
erb-2-transformed NIH-3T3 
ruf-transformed NIH-3T3 
1.8 + 0.3 
0.5 f 0.1 
0.5 f 0.2 
0.5 f 0.1 
0.5 f 0.3 
1.2 r 0.3 
“The increase in cell number of (+q)-cultures was determined 24 h 
after addition of q, and is expressed as fold increase in the cell number 
of (-q)-cultures within the same period. 
proposed to be related to the metabolic state of cells and 
tissues [3]. A relationship between the extent of modifi- 
cation of Q-tRNAs and the proliferative capability of 
tumor cells has been proposed [l l-13,24]. We investi- 
gated the extent of Q-modification of tRNAs in repre- 
sentative cell lines 24 h after addition of q to q-deficient 
cells. Although incomplete, the extent of tRNA modifi- 
cation with q was the same in aerobically and in hypox- 
ically grown serum-supplemented HeLa cells (Table II). 
However, we observed that q cannot be inserted into 
tRNA in hypoxically grown HeLa cells under condi- 
tions when serum factors (growth factors) become limit- 
ing (unpublished results). The tRNAs were completely 
modified with q in NIH-3T3 fibroblasts and in the 
corresponding Ha-ras-transformed fibroblasts. Ad- 
dition of q to A-431, HL-60, Colo-DM320, and EAT 
cells also relieved Q-deficiency of tRNAs in all cases 
(Table II). 
4. DISCUSSION 
The growth-regulating function of isopentenyladen- 
ine and derivatives (cytokinins) in plants has been well 
established [33]. These adenine derivatives are also con- 
stituents of tRNA. Cytokinins can act as inhibitors or 
as promoters of proliferation, depending on the devel- 
opmental stage of cells and on the concentration used. 
They also affect protein synthesis, enzyme activities and 
organellar function. Here we show that the modified 
guanine analogue, queuine, a nutrition factor for mam- 
mals, functions as a growth regulator in mammalian 
cells. Like the cytokinins in plants, q also occurs as a 
free base and as modified nucleoside in tRNA. The 
growth-modulating activity of q probably is of general 
significance for cultured mammalian cells, because 
human, mouse and rat cells of different origin and mor- 
phology were responsive to q-addition. Like cytokinins, 
q also affects cellular parameters uch as protein synthe- 
sis [18], organellar function (mitochondria), and the ac- 
tivity of enzymes such as lactate dehydrogenase and 
superoxide dismutase [30,17]. The responses of mam- 
malian cells to treatment with q appear to be very sim- 
ilar to the responses of plant cells to treatment with 
cytokinines, suggesting that q may have functions in 
mammals that are comparable with the function of cy- 
tokinins in plants. 
Queuine can act as a positive or a negative modulator 
of cell proliferation. What determines whether q inhibits 
or stimulates proliferation? It is a long known phenom- 
enon first described by Warburg [34] that glycolysis is 
increased in tumor cells even under aerobic conditions 
(aerobic glycolysis). This has been shown for EAT cells 
used in this study [35]. Racker et al. described that 
transformation of rat cells with the activated ras gene 
_ but not the myc gene - increases aerobic glycolysis 
[31], suggesting that activation of some - but not all - 
oncogenes may cause a shift of the metabolism towards 
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Fig. 3. Specific LDH activity in aerobically and hypoxically grown 
HeLa cells, and in non-transformed and ras-transformed NIH-3T3 
fibroblasts. Cells were grown without q for 2 days. The culture me- 
dium was exchanged and cells were harvested 24 h later. Total specific 
LDH activity was measured in cytosolic extracts. 
glycolysis under aerobic conditions. Glycolysis is in- 
creased also after exposure of cells to hypoxic condi- 
tions as in the case of HeLa cells. Apparently, q im- 
proves proliferation of cultured mammalian cells under 
conditions that favour respiration, whereas an inhib- 
itory effect of q on proliferation is associated with a shift 
of the energy metabolism towards glycolysis either as a 
consequence of oxygen-limitation, or after transforma- 
tion with those oncogenes that cause an increase in 
aerobic glycolysis. Probably, the Q-system provides a 
means for mammalian cells to regulate proliferation in 
dependence on the metabolic state, and q-deficiency re- 
sults in a loss of this ability, as is the case in HeLa cells. 
Hypomodification of tRNAs of the Q-family is fre- 
quently observed in transformed cells, and has been 
proposed to have some regulatory function. Some ob- 
servations suggested a relation between the extent of 
Q-modification of tRNAs and the malignancy and pro- 
Table II 
Q-modification of tRNAs 24 h after addition of q to q-deficient cells 
Cell line 8 Modified tRNAs” 
HeLa aerobic 68 
HeLa hypoxic 70 
NIH-3T3 100 
Hums transformed NIH-3T3 100 
A-431 100 
Colo-320DM 56 
HL-60 100 
EAT 100 
“In this test, the guanine acceptance of bulk tRNA is determined. Cells 
grown without q contain only Q-deficient tRNAs and the guanine 
acceptance is lOO%, equivalent o 0% Q-modification. No guanine 
acceptance means 100% Q-modification of tRNAs. 
liferative capability of tumor cells [ 11,131. However, Q- 
deficient tRNAs can also be extracted from fast prolif- 
erating undifferentiated cells and regenerating liver [2], 
suggesting that this feature does not exclusively apply 
to cancer cells. Here we showed that addition of q to 
cells that contained only G-tRNAs (q-deficient cells) 
resulted in the appearence of Q in tRNA in any case. 
However, the proliferation of some cell lines was stimu- 
lated whereas that of others was inhibited after q-addi- 
tion. These results suggest hat growth-modulation by 
q is not directly related to the absence or presence of 
Q-containing tRNAs, but depends on the aerobic or 
glycolytic state of cells and on the availability of the free 
q-base. 
Treatment of HeLa cells with q reduces the in vitro 
phosphorylation of a membrane associated protein that 
becomes phosphorylated at tyrosine residues after stim- 
ulation with the epidermal growth factor. Reduced tyro- 
sine phosphorylation of this protein in the presence of 
the q-base is observed also in an in vitro system devoid 
of tRNAs [22]. Furthermore, simultaneous timulation 
of q-deficient intact HeLa cells and A-431 cells with 
EGF and q results in an increased autophosphorylation 
activity of the EGF receptor tyrosine kinase, compared 
with stimulation with EGF in the absence of q [23]. 
Stimulation of autophosphorylation is also observed in 
vitro using either a tRNA-free membrane preparation, 
or the immuno-purified EGF receptor. Treatment of 
q-deficient HeLa cells with low doses of EGF stimulates 
proliferation. This EGF-mediated increase in prolifera- 
tion is completely prevented in the presence of q [23]. 
These data suggest hat the free q-base modulates mito- 
genie signaling pathways by influencing tyrosine phos- 
phorylation of specific proteins involved in growth con- 
trol. Probably, inhibition of proliferation by q, as was 
observed in transformed cells, is achieved through inhi- 
bition of the EGF receptor system that is known to be 
present in most mammalian cells, whereas stimulation 
of proliferation is based on a different mechanism that 
may involve Q-modification of tRNAs as proposed by 
French et al. [24]. The Q-system may be of special signif- 
icance in embryogenesis and in tumorigenesis, where a 
shift from a respiratory to a glycolytic state can be 
observed [36], and where q was found to accumulate [3]. 
The high degree of evolutionary conservation of this 
system throughout the animal kingdom supports this 
assumption. 
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